Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues

被引:273
作者
Arentz-Hansen, H
McAdam, SN
Molberg, O
Fleckenstein, B
Lundin, KEA
Jorgensen, TJD
Jung, G
Roepstorff, P
Sollid, LM [1 ]
机构
[1] Univ Oslo, Rikshosp, Inst Immunol, N-0027 Oslo, Norway
[2] Univ Oslo, Rikshosp, Dept Med, N-0027 Oslo, Norway
[3] Univ Tubingen, Inst Organ Chem, D-7400 Tubingen, Germany
[4] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark
关键词
D O I
10.1053/gast.2002.35381
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Celiac disease is a gluten-induced enteropathy that shows a strong association with HLA-DQ2 and -DQ8. Gluten-specific T cells, invariably restricted by DQ2 or DQ8, can be isolated from celiac lesions. Such gut-derived T cells have a preference for recognition of gluten that has been specifically deamidated by tissue transglutaminase. Only a few gliadin T-cell epitopes have been identified by earlier work. The aim of this study was to perform a systematic characterization of DQ2-restricted T-cell epitopes in alpha- and gamma-gliadins. Methods: Epitopes were identified by mass spectrometry analysis of peptide fragments of recombinant gliadins and by use of synthetic peptides. Results: We identified several new gamma-gliadin epitopes and an additional alpha-gliadin epitope. Interestingly, these and the previously identified epitopes are not randomly scattered across the gliadins but cluster in regions of the proteins with high content of proline residues. Conclusions: Several DQ2-restricted T-cell epitopes exist in gliadin that are located in regions rich in proline. This likely reflects epitope selection at the levels of digestive and antigen-presenting cell processing, transglutaminase-mediated deamidation, and/or peptide binding to DQ2.
引用
收藏
页码:803 / 809
页数:7
相关论文
共 25 条
  • [1] In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope
    Anderson, RP
    Degano, P
    Godkin, AJ
    Jewell, DP
    Hill, AVS
    [J]. NATURE MEDICINE, 2000, 6 (03) : 337 - 342
  • [2] Production of a panel of recombinant gliadins for the characterisation of T cell reactivity in coeliac disease
    Arentz-Hansen, EH
    McAdam, SN
    Molberg, O
    Kristiansen, C
    Sollid, LM
    [J]. GUT, 2000, 46 (01) : 46 - 51
  • [3] The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase
    Arentz-Hansen, H
    Körner, R
    Molberg, O
    Quarsten, H
    Vader, W
    Kooy, YMC
    Lundin, KEA
    Koning, F
    Roepstorff, P
    Sollid, LM
    McAdam, SN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (04) : 603 - 612
  • [4] SPECIFICITY AND PROMISCUITY AMONG NATURALLY PROCESSED PEPTIDES BOUND TO HLA-DR ALLELES
    CHICZ, RM
    URBAN, RG
    GORGA, JC
    VIGNALI, DAA
    LANE, WS
    STROMINGER, JL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01) : 27 - 47
  • [5] FALK K, 1994, IMMUNOGENETICS, V39, P230
  • [6] FLECKENSTEIN B, 2002, IN PRESS J BIOL CHEM
  • [7] HAUSCH F, IN PRESS AM J PHYSL
  • [8] Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides
    Jardetzky, TS
    Brown, JH
    Gorga, JC
    Stern, LJ
    Urban, RG
    Strominger, JL
    Wiley, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) : 734 - 738
  • [9] JUNG G, 1996, COMBINATORIAL PEPTID
  • [10] T-CELLS FROM THE SMALL-INTESTINAL MUCOSA OF A DR4,DQ7 DR4,DQ8 CELIAC-DISEASE PATIENT PREFERENTIALLY RECOGNIZE GLIADIN WHEN PRESENTED BY DQ8
    LUNDIN, KEA
    SCOTT, H
    FAUSA, O
    THORSBY, E
    SOLLID, LM
    [J]. HUMAN IMMUNOLOGY, 1994, 41 (04) : 285 - 291